LSL Pharma Group Boosts Private Placement Funding

LSL Pharma Group Inc (TSE:LSL) has released an update.

LSL Pharma Group Inc., a Canadian pharmaceutical company, has doubled its private placement financing from $3.5 million to $7.5 million after a successful initial closing and conversion of debt. Investors in the placement will receive units priced at $0.40, each comprising a common share and a warrant, with warrants allowing the purchase of additional shares at $0.70 for 36 months post-financing. The offering includes finder’s fees and is subject to regulatory approvals, including from the TSX Venture Exchange.

For further insights into TSE:LSL stock, check out TipRanks’ Stock Analysis page.